Company Filing History:
Years Active: 1995
Title: Innovator in Nucleic Acid Sequencing: Mikhail V Ostrovsky
Introduction: Mikhail V Ostrovsky is a distinguished inventor based in Rockland, Maine, renowned for his contributions to the field of nucleic acid sequencing. With a patent to his name, Ostrovsky has made significant advancements in the development of agarose compositions, which play a vital role in genetic research and molecular biology.
Latest Patents: Ostrovsky's notable patent is titled "Agarose compositions for nucleic acid sequencing." This innovative composition comprises 2 to 10% of a gelling polysaccharide, preferably agarose, along with a denaturing agent, a non-gelling additive such as glycerol, and electrophoretic buffers. The unique formulation allows for the effective resolution of nucleic acid fragments that are at least 50 bases long and differ by at least one base, making it a valuable tool for researchers in the genomics field.
Career Highlights: Mikhail V Ostrovsky is a key member of FMC Corporation, where he has played an instrumental role in advancing technologies related to nucleic acid sequencing. His work has not only contributed to the company's innovative portfolio but has also positioned him as a leader in the scientific community focused on genetic analysis.
Collaborations: Throughout his career, Ostrovsky has collaborated with notable professionals in his field, including David L Harper and Jonathan H Morgan. These collaborations highlight the synergistic effort required for developing groundbreaking solutions in molecular biology and reflect the collaborative spirit prevalent in scientific and research institutions.
Conclusion: Mikhail V Ostrovsky's innovative work in agarose compositions for nucleic acid sequencing exemplifies the impactful contributions of inventors in the realm of biotechnology. His achievements underscore the importance of innovation in enhancing genetic research methodologies, ultimately paving the way for future advancements in this critical field.